Page last updated: 2024-09-05

sorafenib and isoproterenol

sorafenib has been researched along with isoproterenol in 3 studies

Compound Research Comparison

Studies (sorafenib)	Trials (sorafenib)	Recent Studies (post-2010) (sorafenib)	Studies (isoproterenol)	Trials (isoproterenol)	Recent Studies (post-2010) (isoproterenol)
6,520	730	5,251	30,780	803	2,640

Protein Interaction Comparison

Protein	Taxonomy	isoproterenol (IC50)
Beta-2 adrenergic receptor	Homo sapiens (human)	0.246
Beta-1 adrenergic receptor	Homo sapiens (human)	0.333
Beta-2 adrenergic receptor	Rattus norvegicus (Norway rat)	0.2125
Polyunsaturated fatty acid lipoxygenase ALOX15	Oryctolagus cuniculus (rabbit)	1.77
Beta-1 adrenergic receptor	Rattus norvegicus (Norway rat)	0.2125
Beta-3 adrenergic receptor	Rattus norvegicus (Norway rat)	0.2125
Beta-2 adrenergic receptor	Canis lupus familiaris (dog)	0.6667

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Chang, WT; Feng, YH; Lee, K; Liu, PY; Wu, SN	1

Reviews

1 review(s) available for sorafenib and isoproterenol

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

2 other study(ies) available for sorafenib and isoproterenol

Article	Year
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship	2012
Differential Inhibitory Actions of Multitargeted Tyrosine Kinase Inhibitors on Different Ionic Current Types in Cardiomyocytes. International journal of molecular sciences, 2020, Feb-29, Volume: 21, Issue:5 Topics: Action Potentials; Animals; Humans; Ion Channels; Ion Transport; Isoproterenol; Lapatinib; Mice; Myocytes, Cardiac; Neoplasms; Potassium; Potassium Channels; Protein Kinase Inhibitors; Rats; Sodium; Sorafenib	2020

Article

Year

Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.

Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012

Differential Inhibitory Actions of Multitargeted Tyrosine Kinase Inhibitors on Different Ionic Current Types in Cardiomyocytes.

International journal of molecular sciences, 2020, Feb-29, Volume: 21, Issue:5

Topics: Action Potentials; Animals; Humans; Ion Channels; Ion Transport; Isoproterenol; Lapatinib; Mice; Myocytes, Cardiac; Neoplasms; Potassium; Potassium Channels; Protein Kinase Inhibitors; Rats; Sodium; Sorafenib

2020